Journal Article Summary
The article investigates the cost-effectiveness of longer-term versus shorter-term antibiotic treatments for patients experiencing persistent symptoms attributed to Lyme disease. This topic is significant because Lyme disease, a tick-borne illness, can lead to ongoing health issues even after initial treatment, resulting in considerable healthcare costs and a burden on patients' quality of life. Understanding the economic implications of different treatment durations is crucial for healthcare policymakers to make informed decisions about resource allocation and treatment guidelines.
The study was conducted alongside the PLEASE study, which involved 271 patients with persistent Lyme disease symptoms. Participants were randomly assigned to receive either longer-term antibiotic treatments (ceftriaxone combined with doxycycline or clarithromycin and hydroxychloroquine) or a placebo after an initial two-week ceftriaxone treatment. The findings revealed no significant differences in quality-adjusted life years (QALYs) or total societal costs among the treatment groups after one year, suggesting that longer-term treatments do not provide additional benefits compared to shorter-term options.
However, the study has limitations, including missing data and the uncertainty surrounding the attribution of symptoms solely to Lyme disease. Patients should discuss their treatment options with healthcare professionals, especially considering the potential risks of antibiotic resistance associated with prolonged antibiotic use. The study suggests that shorter-term antibiotic regimens may be more appropriate, given the similar effectiveness and cost-effectiveness compared to longer-term treatments.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Berende Anneleen, Nieuwenhuis Lisette, ter Hofstede Hadewych J. M., Vos Fidel J., Vogelaar Michiel L., Tromp Mirjam, van Middendorp Henriët, Donders A. Rogier T., et al.. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease. PLoS ONE 2018. DOI: 10.1371/journal.pone.0195260. PMID: 29608590. PMCID: PMC5880374.
Featured Pill Pals Product
Doxycycline Hyclate 100 MG Capsule --- 1 Pill --- Generic For Vibramycin --- Sun Pharma
Doxycycline Hyclate 100 MG Capsule — 1 Pill — Generic For Vibramycin — Sun Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
